These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 27837164)

  • 21. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.
    Stansfield BK; Wise L; Ham PB; Patel P; Parman M; Jin C; Mathur S; Harshfield G; Bhatia J
    J Pediatr Surg; 2017 Apr; 52(4):609-613. PubMed ID: 27847121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bivalirudin Anticoagulation Dosing Protocol for Extracorporeal Membrane Oxygenation: A Retrospective Review.
    Netley J; Roy J; Greenlee J; Hart S; Todt M; Statz B
    J Extra Corpor Technol; 2018 Sep; 50(3):161-166. PubMed ID: 30250342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of routine laboratory measures of heparin anticoagulation for neonates on extracorporeal membrane oxygenation.
    Sulkowski JP; Preston TJ; Cooper JN; Duffy VL; Deans KJ; Chicoine LG; Minneci PC
    J Extra Corpor Technol; 2014 Mar; 46(1):69-76. PubMed ID: 24779122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nafamostat mesilate as a regional anticoagulant in patients with bleeding complications during extracorporeal membrane oxygenation.
    Park JH; Her C; Min HK; Kim DK; Park SH; Jang HJ
    Int J Artif Organs; 2015 Nov; 38(11):595-9. PubMed ID: 26728787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discordance between ROTEM® clotting time and conventional tests during unfractionated heparin-based anticoagulation in intensive care patients on extracorporeal membrane oxygenation.
    Prakash S; Wiersema UF; Bihari S; Roxby D
    Anaesth Intensive Care; 2016 Jan; 44(1):85-92. PubMed ID: 26673593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-factor Xa vs aPTT for heparin monitoring in extracorporeal membrane oxygenation.
    Vo T; Bello A; Ragan M; Flanagan J; Johnson D
    Am J Health Syst Pharm; 2023 May; 80(Suppl 2):S77-S83. PubMed ID: 36478046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
    Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
    Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO).
    Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ
    Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulants in adult extracorporeal membrane oxygenation: alternatives to standardized anticoagulation with unfractionated heparin.
    Tang S; Xu L; Li H; Wu Z; Wen Q
    Eur J Clin Pharmacol; 2023 Dec; 79(12):1583-1594. PubMed ID: 37740749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unfractionated Heparin Versus Subcutaneous Nadroparin in Adults Supported With Venovenous Extracorporeal Membrane Oxygenation: a Retrospective, Multicenter Study.
    Piwowarczyk P; Borys M; Kutnik P; Szczukocka M; Sysiak-Sławecka J; Szułdrzyński K; Ligowski M; Drobiński D; Czarnik T; Czuczwar M
    ASAIO J; 2021 Jan; 67(1):104-111. PubMed ID: 32404610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Anti-Xa and Activated Partial Thromboplastin Time Monitoring of Heparin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Support.
    Arnouk S; Altshuler D; Lewis TC; Merchan C; Smith DE; Toy B; Zakhary B; Papadopoulos J
    ASAIO J; 2020 Mar; 66(3):300-306. PubMed ID: 31045921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of argatroban in patients receiving extracorporeal membrane oxygenation support: a case-control study].
    Zhang Z; Tang X; Wang R; Li X; Li Y; Tong Z; Sun B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1305-1310. PubMed ID: 36567588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coagulation and anticoagulation in extracorporeal membrane oxygenation.
    Muntean W
    Artif Organs; 1999 Nov; 23(11):979-83. PubMed ID: 10564301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
    Dager WE; Gosselin RC; Yoshikawa R; Owings JT
    Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of heparinized adult veno-arterial extracorporeal membrane oxygenation patients managed with low and high activated partial thromboplastin time targets: A systematic review and meta-analysis.
    Mazzeffi M; Lin D; Gonzalez-Almada A; Stombaugh DK; Curley J; Mangunta V; Teman N; Yarboro LT; Thiele R
    Perfusion; 2024 Apr; 39(3):525-535. PubMed ID: 36595340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation.
    Huang D; Guan Q; Qin J; Shan R; Wu J; Zhang C
    Perfusion; 2023 Sep; 38(6):1133-1141. PubMed ID: 35616224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective Side by Side Comparison of Outcomes and Complications With a Simple Versus Intensive Anticoagulation Monitoring Strategy in Pediatric Extracorporeal Life Support Patients.
    Yu JS; Barbaro RP; Granoski DA; Bauman ME; Massicotte MP; Lequier LL; Annich GM; Ryerson LM
    Pediatr Crit Care Med; 2017 Nov; 18(11):1055-1062. PubMed ID: 28922263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of thromboelastography in the management of anticoagulation for veno-venous extracorporeal membrane oxygenation in a coronavirus disease 2019 patient: A case report.
    Nakashima R; Nishihara M; Iyonaga T; Iwasaka S; Yamamoto Y; Shono Y; Maki J; Tokuda K; Akahoshi T; Higo T; Kitazono T; Tsutsui H
    Medicine (Baltimore); 2021 Jun; 100(23):e26313. PubMed ID: 34115042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombin During Extracorporeal Membrane Oxygenation in Adults: National Survey and Retrospective Analysis.
    Iapichino GE; Protti A; Andreis DT; Panigada M; Artoni A; Novembrino C; Pesenti A; Gattinoni L
    ASAIO J; 2019; 65(3):257-263. PubMed ID: 29746315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a Multimodal Heparin Laboratory Monitoring Protocol in Adult Extracorporeal Membrane Oxygenation Patients.
    Northam KA; Nguyen B; Chen SL; Sredzienski E; Charles A
    J Pharm Pract; 2023 Feb; 36(1):79-86. PubMed ID: 34109859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.